Introduction of CEO
CEO
1987
M.D. Seoul National University College of medicine
1995
M.D./Ph.D. Graduate School of Medicine, Seoul National University
1998
Assistant Professor, SNUCM
1999 - 2000
University of Chicago, USA (Prof. Jeff Bluestone)
2001
Diabetes Center, UCSF, USA (Prof. Jeff Bluestone)
2004
Associate Professor, SNUCM
2009 - present
Professor, SNUCM
2010 - 2012
Vice President of Research, SNUCM
2012 - 2016
Head professor, Department of microbiology and immunology, SNUCM
2012 - 2016
Director, International Xenotransplantation Association (IXA)
2017
President of the Korean Immunology Association
2016 - present
Associate editor, Xenotransplantation(Journal)
2017 - present
Asian Pancreatic/Pancreatic Islet Transplantation Association (Chairman of External Cooperation)
2020 - present
Editorial board member, Cytokine(Journal)
2021 - present
PB Immune Therapeutics Co
Management Team
Jae-Seung Kang
COO
“An exceptional research leader in the field of immunologogy”
1982
MD. SNUCM
1989
PhD, Seoul National University College of Medicine
1989-2023
Professor, Inha university
1992-1994
Research fellow, Harvard Medical School
2023-present
PB Immune Therapeutics Co.
Hyun-Je Kim
CTO
"Introduce the latest immunology research techniques"
2007
Bachelor of Medicine, SNUCM (Medicine)
2008
Specialist, Samsung Seoul Hospital (Dermatology)
2012
Doctor of Medicine, SNU Graduate School of Medicine (Immunology)
2017-2019
Instructor, Ichan School of Medicine at Mount Sinai
2020
Samsung Seoul Hospital Dermatology Research Lecturer
2021-present
Institute of Infectious Diseases, SNUCM
2021-present
PB Immune Therapeutics Co.
Seong-jun Kang
Senior Manager
“Model Analysis of Immunization Disease”
2012
BS, Department of Genetic Engineering, SKKU
2013-2019
Researcher, Bio-Heterogeneous Organ Development Project Group
2014
MD, Seoul National University College of Medicine
2023
PhD, Seoul National University College of Medicine)
2021-present
PB Immune Therapeutics Co.